Personalized Medicine: The Key to Longevity – Insights from MedTech Malta 2024

As healthcare advances by leaps and bounds, personalized medicine is quietly driving a transition from reactive treatments to proactive prevention. At MedTech Malta 2024, the panel discussion Personalized Medicine: The Key to Longevity, powered by lifespin GmbH, explored the groundbreaking developments shaping this field. Moderated by Alex Diaconu, CEO & Co-Founder of AiGIA, the session brought together a distinguished lineup of panelists, each offering unique perspectives on the future of individualized healthcare.   

Panelists included Dr. Ali Tinazli, CEO of lifespin GmbH; Dr. John Thomson Smith, Senior Medical Advisor at RejuveAI; Tony Hsu, CEO of 3×4 Genetics; and Ibrahim Almaghlouth, Director of Clinical Information at NEOM’s Health and Wellbeing Sector. Their discussions highlighted the transformative power of genetics, metabolomics, AI, and decentralized health systems in extending lifespan and enhancing quality of life.

The Vision of lifespin GmbH: Revolutionizing Metabolomics

Dr. Ali Tinazli outlined lifespin GmbH’s ambitious vision to create an omni-intelligent health software platform. He described their innovative approach to capturing metabolomic data from blood samples, which can generate a comprehensive health profile in mere minutes. “We quantitatively capture hundreds of metabolomic parameters that form a phenotype—a dynamic information layer about the individual,” he explained.   

This data can serve multiple functions: facilitating preventative care, enabling precise diagnosis of complex diseases, and monitoring treatment efficacy. lifespin’s current products include a general health assessment tool and a lipoprotein profiler, which evaluates risks for heart attacks, strokes, and insulin resistance. Dr. Tinazli emphasized, “Access to health information is key. Personalized medicine must be accessible and affordable, even in low-resource environments.” lifespin’s work in Madagascar demonstrates how AI-driven health solutions can reduce costs, democratizing access to advanced diagnostics.

Tony Hsu and the Power of Genetics

Tony Hsu, CEO of 3×4 Genetics, shared his company’s mission: to positively impact a billion lives over the next 20 years through genetic insights. He stressed the importance of shifting from a “sick care” model to a preventative one, asserting that personalization is essential for this transition. “Genetic mapping is the cornerstone of personalized medicine,” he said.

Hsu highlighted 3×4 Genetics’ remarkable growth—over 80% year-on-year—and attributed their success to improving patient outcomes. “The bar for patient experience is low. If you can deliver an exceptional experience, you win the market,” he noted. For Hsu, genetics offers unparalleled insight: “When patients see their unique genetic report, a light switch turns on. They realize the data is about them, which motivates behavioral change.”

He emphasized the need to focus on lifestyle-driven diseases, which account for 85% of health issues and are largely preventable. By providing clear, actionable genetic insights, 3×4 Genetics aims to empower individuals to take control of their health proactively.

RejuveAI: Empowering Patients through Data

Dr. John Thomson Smith of RejuveAI introduced their decentralized healthcare data platform, which aims to put patients in control of their data. The upcoming launch of their Definitive app promises to revolutionize health tracking. “Users can integrate data from wearables, biomarkers, and genetic profiles. The unique aspect is that users own their data and get rewarded for contributing it,” he explained.

The platform’s use of cryptocurrency (RJV tokens) incentivizes users to share health data, creating a mutually beneficial ecosystem. Dr. Smith underscored the importance of N-of-1 trials—personalized experiments where individuals track their health changes in response to lifestyle interventions. “Trialing yourself is the future. It’s cost-effective and offers immediate, relevant insights,” he asserted. This model enables users to test interventions and adjust their habits based on real-time feedback, fostering a culture of continuous health improvement.

NEOM’s Holistic Approach to Longevity

Ibrahim Almaghlouth provided a visionary perspective from NEOM, a groundbreaking development in northwest Saudi Arabia. NEOM aims to redefine livability, with health and wellbeing as central pillars. “We’re building a comprehensive ecosystem where wellbeing is the focus by design,” Almaghlouth explained.

NEOM’s strategy integrates genomics, behavioral data, and environmental factors into a hyper-personalized health model. “Our mission is to add healthy lifespan years for each individual,” he noted. Achieving this requires creating a fully integrated system comprising healthcare providers, regulators, and insurers. The goal is to align incentives across the ecosystem, promoting preventive care and ensuring financial sustainability.

The Role of Lifestyle and Metabolomics

The panelists agreed that lifestyle choices significantly impact long-term health outcomes. Dr. Tinazli elaborated on the two layers of the metabolome: the immediate effects of daily habits and the deeper, chronic influences that lead to complex diseases. Monitoring and improving these parameters can prevent inflammation, a key driver of conditions like cardiovascular disease. “I track my own health monthly and see how factors like travel affect my scores. Recovery is possible with lifestyle adjustments,” he shared.

AI and the Future of Personalized Medicine

Artificial intelligence emerged as a recurring theme throughout the discussion. AI enables the analysis of complex data sets—whether genetic, metabolomic, or behavioral—to provide actionable insights. It also facilitates personalized health recommendations and enhances the efficiency of clinical trials. Dr. Smith highlighted the role of AI in enabling N-of-1 trials, allowing individuals to test interventions and receive personalized feedback.

Takeaway

The panel concluded with a shared vision: a future where personalized medicine is accessible, affordable, and integral to everyday life. Advances in genetics, metabolomics, and AI are not just transforming healthcare—they’re empowering individuals to take charge of their health journeys. Whether through lifespin’s metabolomic insights, 3×4 Genetics’ personalized reports, RejuveAI’s data-driven platform, or NEOM’s holistic ecosystem, the path to longevity lies in understanding and leveraging the unique biological blueprint of each individual.

Secure Early Rate Tickets for MedTech Malta 2025!

Do you have a cutting-edge MedTech solution to showcase? Looking to attract investors and present your technology at a premier global event? Reserve your spot at MedTech Malta 2025 now and prepare to connect with industry leaders from around the world!